Polpharma S.A has purchased 85% block of shares of Polfa Warszawa on 19th April in 2012. In a result this agreement has finished the process of  privatization the biggest firm which used to get in to the Polish Pharmaceutical Holding.

The total value of 100%  shares was defined for 957 mln PLN. Polpharma SA has become an owner of 85,14%  Polfa shares. Former owner of these  shares was  Polish Pharmaceutical Holding and State Treasury.

Jan Bury, Financial Secretary in State Treasury, was the special quest of this press conference which  was held at Sheraton Hotel. During his performance he said: "This privatization has finished certain period of country as a owner. I am glad that legacy of first polish medicine fabric is still in "Polish hands”. In behalf of Mikolaj Budzanowski, Minister of State Treasury, I would like to congratulate for this good transaction. I hope, that after next few years, members of this company will say that it was a good investor for Polfa Warsaw.  Polpharma’s offer was the most attractive among other offers from all over the word, which has replied for invitation and were willing to take part in the process of privatization.  Polish company not only offered the best prices condition but also presented an investment plan for developing Polfa Warsaw.

The final condition closing transaction was getting  by Polpharma agreement from Government Competition Office on 26 March in 2012 year. Polpharma will have to banishment any rights to produce by her or Polfa Warsaw medications like Polocard or Acard, Cipronex, Proxacin and Sulfacetamidum natrium, or Sulfacetamidum WZF 10% HEC. Nevertheless, this condition was obvious for each side of transaction.